Search the Appendices of Resolution CM/Res(2018)1
1905 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
PERTUZUMAB | L01FD02 | SI | POM | VALID | ||||
TRASTUZUMAB EMTANSINE | L01FD03 | SI | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | SI | POM | VALID | ||||
PANITUMUMAB | L01FE02 | SI | POM | VALID | ||||
NIVOLUMAB | L01FF01 | SI | POM | VALID | ||||
PEMBROLIZUMAB | L01FF02 | SI | POM | VALID | ||||
DURVALUMAB | L01FF03 | SI | POM | VALID | ||||
AVELUMAB | L01FF04 | SI | POM | VALID | ||||
CEMIPLIMAB | L01FF06 | SI | POM | VALID | ||||
DOSTARLIMAB | L01FF07 | SI | Not authorised | 22-04-2025 | VALID | |||
TISLELIZUMAB | L01FF09 | SI | POM | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
RETIFANLIMAB | L01FF10 | SI | POM | 23-04-2025 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
TORIPALIMAB | L01FF13 | SI | POM | 23-04-2025 | EMEA/H/C/006120 | 19-09-2024 | VALID | |
RAMUCIRUMAB | L01FG02 | SI | POM | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | SI | POM | VALID | ||||
IPILIMUMAB | L01FX04 | SI | POM | VALID | ||||
BRENTUXIMAB VEDOTIN | L01FX05 | SI | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | SI | POM | VALID | ||||
BLINATUMOMAB | L01FX07 | SI | POM | VALID | ||||
ELOTUZUMAB | L01FX08 | SI | Not authorised | VALID | ||||
MOGAMULIZUMAB | L01FX09 | SI | POM | 15-07-2020 | VALID | |||
OLARATUMAB | L01FX10 | SI | Not authorised | VALID | ||||
POLATUZUMAB VEDOTIN | L01FX14 | SI | POM | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | SI | POM | VALID | ||||
AMIVANTAMAB | L01FX18 | SI | POM | VALID | ||||
TREMELIMUMAB | L01FX20 | SI | POM | 18-08-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | SI | POM | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
GLOFITAMAB | L01FX28 | SI | POM | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
TALQUETAMAB | L01FX29 | SI | POM | 23-04-2025 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
ZOLBETUXIMAB | L01FX31 | SI | POM | 22-10-2024 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
ELRANATAMAB | L01FX32 | SI | POM | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | SI | POM | VALID | ||||
NIVOLUMAB AND RELATLIMAB | L01FY02 | SI | POM | VALID | ||||
CARBOPLATIN | L01XA02 | SI | POM | 14-11-2023 | None | VALID | ||
TRASTUZUMAB | L01XC03 | SI | POM | 23-04-2025 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
CETUXIMAB | L01XC06 | SI | POM | 23-04-2025 | VALID | |||
BORTEZOMIB | L01XG01 | SI | POM | VALID | ||||
CARFILZOMIB | L01XG02 | SI | POM | VALID | ||||
VISMODEGIB | L01XJ01 | SI | POM | VALID | ||||
OLAPARIB | L01XK01 | SI | POM | VALID | ||||
TALAZOPARIB | L01XK04 | SI | POM | VALID | ||||
TALIMOGENE LAHERPAREPVEC | L01XL02 | SI | POM | VALID | ||||
TABELECLEUCEL | L01XL09 | SI | POM | 23-04-2025 | EMEA/H/C/004577 | 16-12-2022 | VALID | |
IVOSIDENIB | L01XM02 | SI | POM | 14-11-2023 | EMEA/H/C/005936 | 04-05-2023 | VALID | |
HYDROXYCARBAMIDE | L01XX05 | SI | POM | VALID | ||||
PEGASPARGASE | L01XX24 | SI | POM | VALID | ||||
ARSENIC TRIOXIDE | L01XX27 | SI | POM | VALID | ||||
ANAGRELIDE | L01XX35 | SI | POM | 12-11-2018 | 5363-I-539/05 | 20-07-2005 | VALID | |
ERIBULIN | L01XX41 | SI | POM | 22-10-2024 | None | VALID | ||
AFLIBERCEPT | L01XX44 | SI | POM | VALID |